COMMUNIQUÉS West-GlobeNewswire

Vaxil Bio Licenses P-Esbp for Targeted Cancer Therapy from BGN Technologies, the Technology Transfer Company of Ben-Gurion University, Israel
28/08/2019
NESS-ZIONA, Israel, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Vaxil Bio Ltd (TSX VENTURE: VXL), a biotech company focusing on innovative immunotherapy treatments for cancer and infectious diseases, announced today that it has [...]
Marrone Bio Innovations to Present at Upcoming Investor Conferences
28/08/2019
DAVIS, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (the “Company” or “MBI”) (NASDAQ: MBII), a leading developer of bio-based products for pest management and plant health, today announced [...]
Marrone Bio Innovations CEO Dr. Pam Marrone Receives Innovation Award in Chemistry of Agriculture from the American Chemical Society
28/08/2019
DAVIS, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in sustainable bioprotection and plant health solutions, today announced that Dr. Pam Marrone, [...]
SeaSpine to Present at the 14th Annual Wells Fargo Healthcare Conference
28/08/2019
CARLSBAD, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SeaSpine Holdings Corporation (NASDAQ: SPNE), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced [...]
TRACON Pharmaceuticals to Present at the RHK Capital 4th annual Disruptive Growth Conference hosted by Reed Smith
28/08/2019
SAN DIEGO, Aug. 28, 2019 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (Nasdaq:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer, [...]
Catalyst Pharmaceuticals to Participate in the 14th Annual Citi Biotech Conference on September 4th, 2019
28/08/2019
CORAL GABLES, Fla., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]
Micron Solutions, Inc. Announces $3.7M Contract Award with a Leading Medical Technology Company
28/08/2019
FITCHBURG, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American: MICR) (the “Company”), a diversified contract manufacturing organization, through its wholly-owned subsidiary, Micron Products, [...]
Apellis Pharmaceuticals to Present at Upcoming Investor Conferences
28/08/2019
CRESTWOOD, Ky. and WALTHAM Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Calithera to Participate in Wells Fargo Healthcare Conference and Citi 14th Annual Biotech Conference
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage biotechnology company focused on discovering and developing novel small molecule drugs for the [...]
Mersana Therapeutics to Present at Upcoming Investor Conferences
28/08/2019
CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
Jounce Therapeutics to Present at Upcoming Investor Conferences in September
28/08/2019
CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and predictive biomarkers, [...]
Delcath Systems Announces Presentation at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored by H.C. Wainwright
28/08/2019
NEW YORK, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (“Delcath,” the “Company”, “we”, “our” or “us” (OTCQB: DCTH) will present at the Rodman & Renshaw 21st Annual Global Investment Conference sponsored [...]
CytomX Therapeutics to Present at Upcoming Healthcare Conferences
28/08/2019
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a clinical-stage oncology-focused biopharmaceutical company pioneering a novel class of investigational antibody [...]
Immunomedics to Participate in Upcoming Healthcare Conferences
28/08/2019
MORRIS PLAINS, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
CareDx Acquires XynManagement
28/08/2019
Acquisition solidifies transplant leadership with transplant center quality management and patient waitlist management tools BRISBANE, Calif., Aug. 28, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading [...]
United Health Products Announces Completion of Human Trial Study
28/08/2019
HENDERSON, Nev., Aug. 28, 2019 (GLOBE NEWSWIRE) -- United Health Products, Inc. (OTC: UEEC), (“UHP” or the “Company”), manufacturer and marketer of HemoStyp®, an Oxidized Regenerated Cellulose that is patented through [...]
Voyager Therapeutics to Present at Upcoming Investor Conferences in September 2019
28/08/2019
CAMBRIDGE, Mass., Aug. 28, 2019 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ: VYGR), a clinical-stage gene therapy company focused on developing life-changing treatments for severe neurological diseases, today [...]
FDA Accepts SHINKEI Therapeutics Investigational New Drug Application for MR-301 for Traumatic Brain Injury
28/08/2019
PRINCETON, N.J., Aug. 28, 2019 (GLOBE NEWSWIRE) -- SHINKEI Therapeutics., a clinical stage pharmaceutical company focused on the development of therapeutic drugs for the treatment of Central Nervous System (CNS) [...]
Media Statement Veyonda® Enhances Radiotherapy in Prostate Cancer Treatment Further Promising Results
28/08/2019
SYDNEY, Australia, Aug. 28, 2019 (GLOBE NEWSWIRE) -- Noxopharm (ASX: NOX) (‘ Noxopharm’ or the ‘ Company’ ) today announced the interim three month results from the second part of the DARRT-1 study on its proprietary [...]

Pages